EXHIBIT 16.1
October 4, 2018
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Evolutionary Genomics, Inc.’s statements included under Item 4.01 of its Form 8-K filed on October 4, 2018 and we agree with such statements concerning our firm.
EKS&H LLLP
